FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Allergan Sales Refresh Lacri-Lube Recall

Refresh Lacri-Lube (Mineral Oil 42

Allergan Sales, LLC · Waco, TX

Risk level
Class II
Reported by FDA
Sep 30, 2015
Recall ID
D-1817-2015
Check your lot numberHow we source this data

Summary

Allergan Sales recalled Refresh Lacri-Lube starting Aug 24, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1817-2015 on Sep 30, 2015. Reason: Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

Product description

Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) Net wt. 0.12 oz (3.5 g) tubes (NDC 0023-0312-04) UPC 3 0023-0312-04 2 and b) Net wt. 0.25 oz (7 g) tubes (NDC 0023-0312-07) UPC 3 0023-0312-07 3, Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612.

Lot numbers, UPCs & expiration codes

Lot #: a) 84746, Exp 04/17; 84987, 85087, Exp 05/17; 85359, Exp 06/17; 85721, Exp 07/17; 86045, Exp 08/17; 86406, Exp 09/17; 86594, Exp 10/17; 87021, Exp 11/17; and b) 86470, Exp 09/17; 86829, Exp 10/17; 87105, Exp 11/17

Where it was sold

Nationwide, Puerto Rico, and Barbados

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1817-2015
Classification
Class II
Status
Terminated
Recall initiated
Aug 24, 2015
FDA report date
Sep 30, 2015
Quantity
320,713 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Allergan Sales, LLC

Original FDA data

Every field from FDA enforcement report D-1817-2015, exactly as published.

Show all FDA fields
City
Waco
State
TX
Status
Terminated
Country
United States
Event ID
72016
Address
8301 Mars Dr
Code information
Lot #: a) 84746, Exp 04/17; 84987, 85087, Exp 05/17; 85359, Exp 06/17; 85721, Exp 07/17; 86045, Exp 08/17; 86406, Exp 09/17; 86594, Exp 10/17; 87021, Exp 11/17; and b) 86470, Exp 09/17; 86829, Exp 10/17; 87105, Exp 11/17
Postal code
76712-6578
Report date
Sep 30, 2015
Product type
Drugs
Recall number
D-1817-2015
Classification
Class II
Recalling firm
Allergan Sales, LLC
Product quantity
320,713 tubes
Termination date
Apr 19, 2017
Reason for recall
Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) Net wt. 0.12 oz (3.5 g) tubes (NDC 0023-0312-04) UPC 3 0023-0312-04 2 and b) Net wt. 0.25 oz (7 g) tubes (NDC 0023-0312-07) UPC 3 0023-0312-07 3, Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612.
Distribution pattern
Nationwide, Puerto Rico, and Barbados
Recall initiation date
Aug 24, 2015
Center classification date
Sep 22, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1817-2015, published Sep 30, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls